|Articles|May 29, 2020
COVID-19 pandemic challenges even the best of crisis management plans
Author(s)Ophthalmology Times Staff Reports
Advertisement
Suber S. Huang, MD, MBA, CEO of the Retina Center of Ohio, Cleveland, offers advice for ophthalmologists in these uncharted waters in this interview with Ophthalmology Times®’ Sheryl Stevenson, group editorial director.
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Related Articles
- The European Commission grants marketing authorization for EYLUXVI
September 23rd 2025
- Luxa Biotechnology announces clinical trial results for treatment of AMD
September 22nd 2025
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Idebenone accepted by FDA for priority review for Leber Hereditary Optic Neuropathy
2
Luxa Biotechnology announces clinical trial results for treatment of AMD
3
STAAR Surgical confirms expiration of “window shop” period in Alcon merger agreement
4
The European Commission grants marketing authorization for EYLUXVI
5